# Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

Study · id `cardio:ct-nct03174821` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03174821](<https://clinicaltrials.gov/study/NCT03174821>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03174821

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT03174821. Non-randomized; no masking; primary purpose treatment. Start 2010-10-20 (actual); primary completion 2014-05-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT03174821, source copy `cardio:ctgov-nct03174821-2017-06-05`, retrieved 2026-10-26)
- Started: 2010-10-20 (actual) (ClinicalTrials.gov record NCT03174821, source copy `cardio:ctgov-nct03174821-2017-06-05`, retrieved 2026-10-26)
- Primary completion: 2014-05-16 (actual) (ClinicalTrials.gov record NCT03174821, source copy `cardio:ctgov-nct03174821-2017-06-05`, retrieved 2026-10-26)
- Completion: 2014-05-16 (actual) (ClinicalTrials.gov record NCT03174821, source copy `cardio:ctgov-nct03174821-2017-06-05`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03174821-2017-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy
- Condition: Insulin Pump Therapy in Treating Diabetic Nephropathy
- Intervention (Device): Insulin pump
- Lead sponsor: Chinese PLA General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Chinese PLA General Hospital (`cardio:org-chinese-pla-general-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy (`cardio:pubmed-29433562`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4e744d5fbfe7994d08100d72f905f8ef970a13f0d304419fd2e3004aae868a22
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
